AMRI, a contract research and manufacturing organization, has received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for drug substance development and manufacturing services related to the synthesis and analysis of small molecules in support of the Division of Pre-Clinical Innovation’s (DPI) drug development programs.

Through this contract, AMRI will support the DPI scientists to advance early-stage NCATS drug discovery projects from candidate nomination to clinical trials by providing services related to process development, analytical development, and GMP manufacture of small molecule drug candidates to support clinical trials. The goal of the DPI is to advance collaborative research projects across pre-clinical phases of the translational science spectrum.

Source: AMRI